AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

Below is a collection of 10 charts that tell the story of market and economic resiliency in 2024 — with all eyes set on 2025. It was a record-setting year on Wall Street, with the S&P 500 ...

DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...

From the triumph of Donald Trump to the rise of the world’s richest man, Morning Joe economic analyst Steve Rattner charts the 10 stories that defined 2024.Jan. 2, 2025 A defense of capitalism ...

Perhaps January is the cruellest month. The NHS began 2024 without any planning guidance for 2024/25, a further junior doctors strike, and parliamentarians observing that dental appointments were ...

Health insurance rules capping monthly out-of-pocket costs for insulin, asthma inhalers, and epinephrine injectors took effect on New Year’s Day. The provisions, required under a law Gov. Phil Murphy ...

keeping hold of its first place position at the top of the Mass Market Fiction chart. In total this week, volume sales have dropped 45.3% to 4.8 million, delivering sales of £48.1m, a decline of 46%.